Early safety testing begins for new drug combinations
NCT ID NCT07128654
Summary
This early-stage study tested the safety and how the body processes two different drug combinations in healthy volunteers. Forty participants received either a combination of two drugs (CTL0201 and CTL0202) or a single drug (CT-L02) in a crossover design. Researchers measured drug levels in the blood and monitored for side effects to gather initial safety data.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
H+ Yangji Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.